Howard University
↗Washington, D.C., USA
Howard University is a private, federally chartered historically Black research university (HBCU) in Washington, D.C. It is a leading institution for pharmaceutical and medical research, particularly focused on health disparities, minority health, and chronic diseases. The university encompasses the Howard University College of Medicine, the College of Pharmacy, and the Howard University Hospital, which serves as a primary teaching facility and a major site for clinical trials.
In 2025, Howard became the first HBCU to achieve the 'R1: Doctoral University – Very high research activity' Carnegie Classification, the highest tier for research institutions in the United States. The university's research infrastructure is bolstered by the Howard University Urban Health Clinical Research Network (HUCRN) and the Interdisciplinary Research Building (IRB), which facilitate high-impact studies in oncology, immunology, and infectious diseases in collaboration with global pharmaceutical partners.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Academic Research & Clinical Trials
SIZE & FINANCIALS
Employees:5001-10000
Revenue:$1B-$5B
Founded:1867
Ownership:nonprofit
Status:operating
FUNDING
Total Raised:$1.3B+ (Annual Revenue/Grants)
Investors:National Institutes of Health (NIH), National Cancer Institute (NCI), MacKenzie Scott, Sanofi, Abbott, Gilead Sciences
PIPELINE
Stage:Discovery
Lead Drug Stage:Preclinical
Modalities:Small molecule, Cell therapy, Gene therapy, mAb, Vaccines, Nanoparticles
Active Trials:45
Trial Phases:Phase 1: 12 | Phase 2: 15 | Phase 3: 10 | Phase 4: 8
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Howard University Hospital, Howard University College of Medicine, Howard University College of Pharmacy
Key Partnerships:Sanofi ($18M partnership for clinical study diversity), Johns Hopkins Medicine (H2CAREE alliance for cancer research), BioMarin (Regulatory Affairs fellowship), Abbott ($1M clinical research diversity grant), GSK (Global Medical Information fellowship), Amgen (Biotech fellowship program)
COMPETITION
Position:Leader
Competitors:Morehouse School of Medicine, Meharry Medical College, Georgetown University, George Washington University
LEADERSHIP
Key Executives:
Dr. Wayne A. I. Frederick - Interim President
Dr. Anthony Wutoh - Provost and Chief Academic Officer
Dr. Andrea A. Hayes Dixon - Dean, College of Medicine
Dr. Oluwaranti Akiyode - Dean, College of Pharmacy
Board Members:Leslie D. Hale (Chair), Mark A. L. Mason (Vice Chair), Kevin E. Lofton (Trustee)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Howard University. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.